Abstract:With our current appreciation of the complexity of eukaryotic transcription, whose dysregulation drives diseases including cancer, it is becoming apparent that identification of key events coordinating multiple aspects of transcriptional regulation is of special importance. To elucidate how assembly of RNA polymerase II (Pol II) with Mediator complex preinitiation complexes (PICs) and formation of transcription-permissive 3D chromatin organization are coordinated, we studied MED1, a representative subunit of the Mediator complex that acts to establish functional preinitiation complexes (PICs) that forms biomolecular condensates through an intrinsically disordered region (IDR) to facilitate transcription , and is implicated in the function of estrogen receptor α (hereafter ER) in ER-positive breast cancer (ER BC) cells . We found that MED1 is acetylated at 6 lysines in its IDR and, further, that MCF7 ER BC cells in which endogenous MED1 is replaced by an ectopic 6KR (non-acetylatable) mutant (6KR cells) exhibit enhanced cell growth and elevated expression of MED1-dependent genes. These results indicate an enhanced function of 6KR MED1 that may be attributed to two mechanisms: (1) reorganized PIC assembly, as indicated by increased MED1 and Pol II, decreased MED17, and equivalent ERα occupancies on chromatin, particularly at active enhancers and promoters; (2) sub-TAD chromatin unfolding, as revealed by HiCAR (Hi-C on accessible regulatory DNA) analyses. Furthermore, in vitro assays demonstrate distinct physio-chemical properties of liquid-liquid phase separation (LLPS) for 6KR versus 6KQ MED1 IDRs, and for non-acetylated versus CBP-acetylated WT MED1 IDR fragments. Related, Pol II CTD heptads are sequestered in 6KR and control WT MED1 IDR condensates, but not 6KQ and CBP-acetylated WT MED1 IDR condensates. These findings, in conjunction with recent reports of PIC structures , indicate that MED1 coordinates reorganization of the PIC machinery and the rewiring of regional chromatin organization through acetylation of its IDR. This study leads to an understanding of how the transition in phase behavior of a transcription cofactor acts as a mechanistic hub integrating linear and spatial chromatin functions to support gene expression, and have potential therapeutic implications for diseases involving MED1/Mediator-mediated transcription control.

Structural basis of the human transcriptional Mediator regulated by its dissociable kinase module

Structural basis of the human transcriptional Mediator complex modulated by its dissociable Kinase module

Mediator Structure and Interaction with the Basal Transcription Machinery

Structural Flexibility and Functional Interaction of Mediator Cdk8 Module

Architecture of the Mediator Head Module

The Mediator complex as a master regulator of transcription by RNA polymerase II

Structures of the human Mediator and Mediator-bound preinitiation complex

Mediator structure and conformation change

Mediator structural conservation and implications for the regulation mechanism.

MED1 IDR acetylation reorganizes the transcription preinitiation complex, rewires 3D chromatin interactions and reprograms gene expression

Redefining the modular organization of the core Mediator complex.

The Mediator complex regulates enhancer-promoter interactions

Interaction of the mediator head module with RNA polymerase II.

Mediator and RNA polymerase II clusters associate in transcription-dependent condensates

Mediator Med23 Regulates Basal Transcription In Vivo Via An Interaction With P-Tefb

The Mediator complex: a central integrator of transcription

The Mediator Complex: a Master Coordinator of Transcription and Cell Lineage Development.

Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors

The Mediator Subunit MED23 Couples H2B Mono‐ubiquitination to Transcriptional Control and Cell Fate Determination

Mediator Complex——Central Controller of Eukaryotic Transcription

Connection of core and tail Mediator modules restrains transcription from TFIID-dependent promoters